• Published 23 Aug 2024

CatSci to participate at a panel discussion at PharmaTech Integrates 2024

  • Events

CatSci Ltd, an award-winning innovation partner for medicines development, is excited to announce that we will be sponsoring and attending PharmaTech Integrates 2024. Our Director of New Modalities, Dr Nigel Richardson, will also be participating in a panel discussion entitled ‘The Oligos/Peptides Revolution for Patients, the NHS, and the UK Economy.’

Taking place on 19th September 2024, PharmaTech Integrates will be held in Glasgow, Scotland.

We are looking forward to discussing how CatSci can meet your dynamic project demands with tailored solutions in oligonucleotides CMC development.

Attending PharmaTech Integrates 2024 will be: 

  • Dr Nigel Richardson, Director of New Modalities
  • Dr Sam Whitmarsh, Director of Analytical Science and Digital Transformation
  • Dr Joe Renny, Head of Corporate Development

Book a meeting with us to discover more about CatSci’s oligonucleotides capabilities:  

  • Material Supply
  • Process R&D
  • Analytical Science
  • CMC

To arrange a meeting at PharmaTech Integrates 2024, get in touch here.  

Find out more about our expert oligonucleotides services here.

Resources & Insights

  • 12 Aug 2026
  • Rob Crook
Don’t Forget Metrics: How Do We Prove Chemistry Is Actually Green?
  • Green Chemistry
  • Thought Leaders
  • 10 Aug 2026
  • Rob Crook
Innovate Following Nature’s Lead: How Would Nature Solve This Problem?
  • Green Chemistry
  • Thought Leaders
  • 12 Jun 2026
  • Joseph Renny, Simon N. G. Tyler
From Undruggable to Inevitable: Fifteen years of drug development — and what comes next 
  • Artificial Intelligence (AI)
  • Process R&D
  • Thought Leaders
  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News